Icad Shares Outstanding

ICAD Stock

USD 1.29 0.01 0.78%

Icad Inc fundamentals help investors to digest information that contributes to Icad's financial success or failures. It also enables traders to predict the movement of Icad Stock. The fundamental analysis module provides a way to measure Icad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icad stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Receivables Inventories

Icad Shares Outstanding Analysis

Icad's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

	2020	2021	2022	2023 (projected)
Interest Expense	476 K	141 K	126.9 K	130.24 K
Gross Profit	21.35 M	24.24 M	21.82 M	21.15 M

Interest Expense Gross Profit

Shares Outstanding

Public Shares

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Icad Shares Outstanding

25.45 M

Most of Icad's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Icad Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Icad is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Outstanding. Since Icad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icad's interrelated accounts and indicators.

Click cells to compare fundamentals

Icad Shares Outstanding Historical Pattern

Today, most investors in Icad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Icad's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Icad shares outstanding as a starting point in their analysis.

Icad Shares Outstanding

Timeline

Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Competition

Predict Icad

Weighted Average Shares Over Time

Based on the latest financial disclosure, Icad Inc has 25.45 M of shares currently outstending. This is 85.9% lower than that of the Health Care Technology sector and 85.45% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 95.55% higher than that of the company.

Icad Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.

Icad is currently under evaluation in shares outstanding category among related companies.

Icad Current Valuation Drivers

We derive many important indicators used in calculating different scores of Icad from analyzing Icad's financial statements. These drivers represent accounts that assess Icad's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icad's important valuation drivers and their relationship over time.

	2018	2019	2020	2021	2022	2023 (projected)
Net Income Per Employee	(92.96 K)	(98.2 K)	(154.05 K)	(82.08 K)	(73.87 K)	(79.7 K)
Revenue Per Employee	264.13 K	227.1 K	259.8 K	245.53 K	282.36 K	301.9 K
Average Assets	29.1 M	39.29 M	47.28 M	67.5 M	60.75 M	54.23 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	(7.76 M)	(12.05 M)	(16.52 M)	(10.55 M)	(9.49 M)	(10.24 M)
Earnings Before Interest Taxes and Depreciation Amortization USD	(7.76 M)	(12.05 M)	(16.52 M)	(10.55 M)	(9.49 M)	(10.24 M)
Earnings before Tax	(8.97 M)	(13.51 M)	(17.57 M)	(11.24 M)	(10.12 M)	(10.92 M)
Average Equity	9.72 M	7.18 M	24.36 M	50.18 M	45.16 M	36.14 M
Enterprise Value	61.34 M	153.32 M	290.71 M	146.27 M	168.21 M	153.37 M
Free Cash Flow	(4.17 M)	(7.4 M)	(7.45 M)	(9.97 M)	(8.97 M)	(9.21 M)
Invested Capital	9.5 M	20.54 M	11.15 M	5.06 M	5.82 M	7.48 M
Invested Capital Average	5.82 M	16.51 M	10.77 M	8.18 M	9.4 M	9.4 M
Market Capitalization	62.06 M	150.42 M	303.51 M	180.79 M	207.91 M	179.39 M
Tangible Asset Value	21.82 M	32.2 M	46.33 M	53.15 M	61.12 M	50.91 M
Working Capital	7.97 M	10.36 M	25.55 M	35.34 M	40.65 M	43.85 M

Icad Fundamentals

	Return On Equity	(0.34) %
	Return On Asset	(0.15) %
	Profit Margin	(0.50) %
	Operating Margin	(0.50) %
	Current Valuation	20.38 M
	Shares Outstanding	25.45 M
	Shares Owned by Insiders	7.31 %
	Shares Owned by Institutions	45.33 %
	Number of Shares Shorted	266.46 K
	Price to Earning	(8.32) X
	Price to Book	1.11 X
	Price to Sales	1.56 X
	Revenue	33.64 M
	Gross Profit	24.56 M
	EBITDA	(11.15 M)
	Net Income	(11.24 M)
	Cash and Equivalents	27.18 M
	Cash per Share	1.07 X
	Total Debt	3.16 M
	Debt to Equity	0.08 %
	Current Ratio	3.19 X
	Book Value Per Share	1.49 X
	Cash Flow from Operations	(9.41 M)
	Short Ratio	2.06 X
	Earnings Per Share	(0.58) X
	Price to Earnings To Growth	(0.56) X
	Target Price	5.0
	Number of Employees	136
	Beta	1.21
	Market Capitalization	32.57 M
	Total Asset	62.19 M
	Retained Earnings	(242.03 M)
	Working Capital	13.49 M
	Current Asset	27.77 M
	Current Liabilities	14.28 M
	Z Score	1.8
	Net Asset	62.19 M

About Icad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Share Portfolio Now

Share Portfolio

Track or share privately all of your investments from the convenience of any device

All Next

Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Icad Piotroski F Score and Icad Altman Z Score analysis. For information on how to trade Icad Stock refer to our How to Trade Icad Stock guide. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.

	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	CEO Directory Screen CEOs from public companies around the world
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Analyst Recommendations Analyst recommendations and target price estimates broken down by several categories
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Watchlist Optimization Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Piotroski F Score Get Piotroski F Score based on binary analysis strategy of nine different fundamentals

Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.58)

Revenue Per Share

1.163

Quarterly Revenue Growth

(0.32)

Return On Assets

(0.15)

Return On Equity

(0.34)

The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

	Accounts Payable	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Shareholders Equity	Total Liabilities	Current Liabilities	Tax Liabilities
Accounts Payable		-0.01	0.65	0.59	-0.3	-0.36	-0.51	0.2	-0.36	-0.06	-0.33
Total Assets	-0.01		0.42	0.53	0.12	0.49	0.72	0.84	0.33	0.62	-0.07
Current Assets	0.65	0.42		0.99	-0.47	-0.28	-0.19	0.67	-0.4	0.1	-0.39
Cash and Equivalents	0.59	0.53	0.99		-0.41	-0.19	-0.1	0.74	-0.32	0.13	-0.4
Total Debt	-0.3	0.12	-0.47	-0.41		0.87	0.31	-0.43	0.95	0.52	-0.15
Debt Current	-0.36	0.49	-0.28	-0.19	0.87		0.59	-0.02	0.92	0.67	-0.07
Deferred Revenue	-0.51	0.72	-0.19	-0.1	0.31	0.59		0.43	0.52	0.68	0.25
Shareholders Equity	0.2	0.84	0.67	0.74	-0.43	-0.02	0.43		-0.24	0.24	0.0
Total Liabilities	-0.36	0.33	-0.4	-0.32	0.95	0.92	0.52	-0.24		0.67	-0.12
Current Liabilities	-0.06	0.62	0.1	0.13	0.52	0.67	0.68	0.24	0.67		-0.18
Tax Liabilities	-0.33	-0.07	-0.39	-0.4	-0.15	-0.07	0.25	0.0	-0.12	-0.18

Icad Shares Outstanding

Icad Shares Outstanding Analysis

Current Icad Shares Outstanding

Icad Shares Outstanding Driver Correlations

Icad Shares Outstanding Historical Pattern

Icad Shares Outstanding Peer Comparison

Icad Current Valuation Drivers

Icad Fundamentals

About Icad Fundamental Analysis

Be your own money manager

Did you try this?

Run Share Portfolio Now

Share Portfolio

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Icad Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY